Trivalent inactivated influenza virus vaccine in children with inborn errors of metabolism who are at risk of decompensation

Trial Profile

Trivalent inactivated influenza virus vaccine in children with inborn errors of metabolism who are at risk of decompensation

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Jan 2014

At a glance

  • Drugs Influenza virus vaccine (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 16 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top